Neuberger Berman Group LLC Holding In Johnson & Johnson (JNJ) Was Has Lifted

December 8, 2017 - By Marie Mckinney

Investors sentiment decreased to 0.83 in Q2 2017. Its down 0.03, from 0.86 in 2017Q1. It fall, as 50 investors sold JNJ shares while 878 reduced holdings. 105 funds opened positions while 667 raised stakes. 1.73 billion shares or 0.03% less from 1.73 billion shares in 2017Q1 were reported. Hendley & holds 4.49% or 60,972 shares in its portfolio. Cahill Financial Advisors Inc has 0.47% invested in Johnson & Johnson (NYSE:JNJ) for 6,381 shares. Sentinel Tru Lba invested in 9,521 shares or 0.21% of the stock. Atwood And Palmer reported 30,674 shares. Clarkston Capital Ptnrs Lc accumulated 321,791 shares. Diamond Hill Cap Management, Ohio-based fund reported 2,184 shares. Hm Capital Management Limited Liability Corp holds 1.33% or 10,871 shares. 23,607 were accumulated by Martin Com Inc Tn. Pineno Levin Ford Asset Mgmt Incorporated reported 55,215 shares or 3.45% of all its holdings. Shoker Counsel owns 19,891 shares or 2.07% of their US portfolio. Stack Financial Management reported 1.18% of its portfolio in Johnson & Johnson (NYSE:JNJ). Lincluden Ltd reported 104,364 shares or 1.19% of all its holdings. Hartwell J M LP stated it has 0.84% in Johnson & Johnson (NYSE:JNJ). Riverbridge Prtn Limited Liability has 0.07% invested in Johnson & Johnson (NYSE:JNJ) for 28,615 shares. Trb Lp holds 1.39% or 15,000 shares in its portfolio.

Neuberger Berman Group Llc increased its stake in Johnson & Johnson (JNJ) by 2.6% based on its latest 2017Q2 regulatory filing with the SEC. Neuberger Berman Group Llc bought 126,383 shares as the company’s stock rose 6.85% with the market. The institutional investor held 4.99 million shares of the major pharmaceuticals company at the end of 2017Q2, valued at $659.48 million, up from 4.86 million at the end of the previous reported quarter. Neuberger Berman Group Llc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $376.14B market cap company. The stock decreased 0.74% or $1.05 during the last trading session, reaching $140.01. About 4.71M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since December 8, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.

Neuberger Berman Group Llc, which manages about $77.86 billion US Long portfolio, decreased its stake in Suntrust Banks Inc (NYSE:STI) by 272,229 shares to 54,830 shares, valued at $3.11 million in 2017Q2, according to the filing. It also reduced its holding in Hill Rom Holdings Inc (NYSE:HRC) by 75,365 shares in the quarter, leaving it with 1.40M shares, and cut its stake in Wabtec Corp (NYSE:WAB).

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Johnson & Johnson: Reliable Dividend Clipper” on December 08, 2017, also Fool.com with their article: “3 Dividend Stocks That Pay You More Than Johnson & Johnson Does” published on December 04, 2017, Seekingalpha.com published: “Johnson & Johnson: Buy The Pause” on November 29, 2017. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Fiercebiotech.com and their article: “Johnson & Johnson’s JLABS looks east as it lands in Shanghai” published on December 05, 2017 as well as Forbes.com‘s news article titled: “The Outlook For Johnson & Johnson’s Immunology Drug Business” with publication date: December 05, 2017.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 13 have Buy rating, 5 Sell and 5 Hold. Therefore 57% are positive. Johnson & Johnson has $165 highest and $90 lowest target. $136.94’s average target is -2.19% below currents $140.01 stock price. Johnson & Johnson had 83 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Wells Fargo on Wednesday, October 18. The firm has “Buy” rating given on Monday, July 10 by BMO Capital Markets. The firm has “Hold” rating by Jefferies given on Tuesday, March 15. The firm has “Hold” rating by Jefferies given on Tuesday, June 14. RBC Capital Markets maintained Johnson & Johnson (NYSE:JNJ) rating on Friday, September 22. RBC Capital Markets has “Buy” rating and $144.0 target. UBS maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, July 19 with “Buy” rating. Cowen & Co maintained the shares of JNJ in report on Thursday, August 24 with “Buy” rating. UBS maintained Johnson & Johnson (NYSE:JNJ) on Thursday, August 31 with “Buy” rating. BMO Capital Markets maintained the shares of JNJ in report on Friday, June 2 with “Buy” rating. On Thursday, October 19 the stock rating was maintained by Credit Suisse with “Buy”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.